Quốc gia: Canada
Ngôn ngữ: Tiếng Anh
Nguồn: Health Canada
MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE)
MYLAN PHARMACEUTICALS ULC
J01MA14
MOXIFLOXACIN
400MG
TABLET
MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) 400MG
ORAL
100
Prescription
QUINOLONES
Active ingredient group (AIG) number: 0142242001; AHFS:
CANCELLED PRE MARKET
2017-01-11
_ _ _ _ _Page 1 of 61_ PRODUCT MONOGRAPH Pr MYLAN-MOXIFLOXACIN Moxifloxacin Hydrochloride Tablets 400 mg Moxifloxacin (as Moxifloxacin Hydrochloride) Antibacterial Agent Mylan Pharmaceuticals ULC 85 Advance Road Etobicoke, ON M8Z 2S6 Date of Revision: November 15, 2016 Submission Control No: 199712 _ _ _ _ _Page 2 of 61_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................................ 3 SUMMARY PRODUCT INFORMATION ....................................................................... 3 INDICATIONS AND CLINICAL USE ............................................................................. 3 CONTRAINDICATIONS .................................................................................................. 4 WARNINGS AND PRECAUTIONS ................................................................................. 4 ADVERSE REACTIONS ................................................................................................. 12 OVERDOSAGE ............................................................................................................... 21 ACTION AND CLINICAL PHARMACOLOGY ........................................................... 21 STORAGE AND STABILITY ......................................................................................... 29 SPECIAL HANDLING INSTRUCTIONS ...................................................................... 29 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................................ 28 PART II: SCIENTIFIC INFORMATION .............................................................................. 30 PHARMACEUTICAL INFORMATION ......................................................................... 30 CLINICAL TRIALS ......................................................................................................... 31 DETAILED PHARMACOLOGY .................................................................................... 40 MICROBIOLOGY ....................................................... Đọc toàn bộ tài liệu